Contraceptives Market Size & Share, by Product Type (Drugs, Devices, Condoms, Vaginal Rings, Implants, Injectables); Age (15-44 Years, Above 44 Years); Gender (Male, Female); End-user (Homecare, Clinics, Hospitals, Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4635
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2033

Contraceptives Market size is expected to reach USD 45 Billion by the end of 2033, witnessing around 6% CAGR during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of contraceptives was USD 26 Billion.  The rising need for effective family planning and government initiatives and support to raise awareness about birth control is estimated to have a positive impact on market growth. In 2020, the U.S. government invested about USD 600 million to enhance family planning and provide reproductive health services across the world.

In addition to the aforementioned factors, the rising focus on preventing unintended pregnancy is anticipated to boost the market growth of the global contraceptives market. As per the estimations, about half of all pregnancies occurring in the world are unwanted i.e., nearly 120 million pregnancies every year are unintended. Moreover, increased awareness about health issues associated with teenage pregnancies and high abortion rates among the population are other factors that are projected to create a positive outlook for market expansion. Also, the increase in participation of reproductive women in the labor force, the implementation of programs at reducing unwanted pregnancies, and the high number of women with unmet contraceptive drugs and devices are other factors that are expected to boost the expansion of the market size. Furthermore, the growing prevalence of sexually transmitted diseases (STDs) is also anticipated to increase the sales of contraceptives in the upcoming years.

Get more information on this report: Request Free Sample PDF

Contraceptives Sector: Growth Drivers and Challenges

Growth Drivers

  • Effective to Reduce Teen Pregnancies - According to the statistics by the UNICEF, about 14% of adolescent girls and young women were known to give birth at a younger age before 18 globally in the year 2021. The data also stated that maternal conditions, which registered 507 DALYs (per 100,000 population) among the adolescent girls had the 4th position among the top 5 causes of disability affected life years (DALYs). In the recent period, owing to the less level of awareness about sex and sex education, the number of teen pregnancies has seen an escalation. Thus, the use of contraceptives is estimated to boost market growth as well as reduce teen pregnancies more effectively. It is also observed that 85% of the decline in teen pregnancies worldwide is on account of improvements in contraceptive usage, this is confirmed owing to the evidence that there is no decline in the rate of intercourse. According to the Centers for Disease Control and Prevention, the teen birth rate in the U.S. reduced to 16.7 per 1000 females in 2019, from 17.4 per 1000 females in 2018.

  • Growing Disposable Income - With the rising disposable income, the spending capacity of individuals also grows to make them capable of buying extra things. Therefore, with more income level of the population, the sales of contraceptives are anticipated to rise to avoid pregnancies. The disposable income of the U.S. in August 2022 rose to 0.1% up from -0.4% in June 2022 as per the Bureau of Economic Analysis.

  • Rising World Population - In the recent period, the world population has seen an explosion with thousands of births every single day. As a result, it is growing pressure on the economy. Thus, to curb the growing population rate, the consumption of contraceptives is estimated to soar during the analysis period. It is observed that the world’s population would rise to 2 billion people by the end of 2050 up from 8 billion people in 2020.

  • Elevating Risk of Abortion - Medical professionals have stated that abortion is associated with high risks including pelvic infection, blood clots in the uterus, heavy bleeding, cuts in the cervix, perforation of the wall of the uterus, and others. Thus, to reduce abortion cases, contraceptives are treated to be an effective way, which in turn, is anticipated to bring lucrative growth opportunities for market growth.  As per the World Health Organization, about 73 million abortions occur every year in the world.

  • Rising Government Support to Control Population - With the implementation of favorable policies in regard to population control, the utilization rate of contraceptives is expected to increase among consumers. In 2005, the Indian Government launched National Family Planning Indemnity Scheme (NFPIS) and passed Population (Control, Stabilization, and Welfare) Bill in 2021.


  • Side Effects such as Nausea and Headache Associated with the Use of Contraceptives – Birth control pills, the most common contraceptives are stated to have negative effects on the human body which include sore breasts, weight gain, decreased sex drive, frequent mood changes, spotting or bleeding between menstrual cycles, and others. Thus, the rising concerns regarding the side effects are estimated to decrease the consumption rate of contraceptives in the forecast period.
  • Health Risk with the Use of Contraceptives
  • Lack of Social Acceptance

Contraceptives Market: Key Insights

Base Year


Forecast Year




Base Year Market Size (2022)

~USD 26 Billion

Forecast Year Market Size (2033)

~USD 45 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Contraceptives Segmentation

End-user (Homecare, Clinics, Hospitals, Pharmacies)

The global contraceptives market is segmented and analyzed for demand and supply by end-user into home care, clinics, hospitals, and pharmacies. Out of these, the pharmacies segment is anticipated to hold the largest market size by the end 0f 2033 on account of the rising manufacturing rate of birth control pills and availability of a wide range of contraceptive options to buy from retail pharmacies without a prescription such as condoms, spermicides, and intrauterine devices. As per the statistical estimations, about 34 million Americans used condoms during intercourse to prevent pregnancy in 2020. Also, the collaboration of pharmacies with hospitals to distribute contraceptives is anticipated to fuel the revenue generation of the segment. Furthermore, the presence of pharmacies in every region along with easy availability makes pharmacies an ideal option to buy contraceptives. On the other hand, the hospital segment is also projected to grow steadily in the assessment period. The rising number of gynecologists present in hospital settings prescribing contraceptives is a major factor for segment growth. Also, the availability of safe and reliable contraceptive devices in hospitals under doctors’ guidance is forecasted to bring a favorable chance for segment growth.

Gender (Male, Female)

The global contraceptives market is also segmented and analyzed for demand and supply by gender into male and female. Out of these two, the male segment is anticipated to grow with a significant CAGR in the forecast period. The major factor attributed to segment growth is the availability of male contraceptives in the market. Male condoms are considered to be the most used and easily accessible contraceptives. A recent report of 2020 stated that over 450 million condoms are sold every year in the United States.

Our in-depth analysis of the global market includes the following segments:

                  By Product Type

  • Drugs
  • Devices
  • Condoms
  • Vaginal Rings
  • Implants
  • Injectables

                 By Age

  • 15-44 Years
  • Above 44 Years

                 By Gender

  • Male
  • Female

                  By End-User

  • Homecare
  • Clinics
  • Hospitals
  • Pharmacies

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Contraceptives Industry - Regional Synopsis

North American Market Forecast   

The North America contraceptives market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The rising demand for contraceptive pills and growing awareness among people on various contraceptive options such as female condom, injectable contraceptives, and so on are estimated to boost the market growth during the forecast period. In a research survey conducted in the United States in the year 2022, it has been observed that around 80% or over 3-quarter of reproductive age females reported that they would favor having the availability of OTC birth control pills without having a prescription for the same. Also, the presence of a large population is anticipated to propel market growth. Furthermore, the number of unintended pregnancies especially in the teenage group is anticipated to augment regional growth. As per the data from the Centers for Disease Control and Prevention, nearly 14% of women aged 15-49 used contraceptive pills in the U.S. to prevent the risk of unwanted pregnancy during 2017-2018. In addition, the growth in Sexually Transmitted Diseases (STDs) and rising government awareness programs to tackle the burgeoning population is anticipated to favor the sales of contraceptives in the region. Rising commercialization of contraceptives by major key players along with expanding disposable income of the population is expected to impetus the growth of the global contraceptives market in the North America region.

APAC Market Statistics

On the other hand, the market in the Asia Pacific region is also estimated to grow with a significant share and hold a notable market share. The major factors attributed to the growth of the market are the rising population and the increased number of babies born each year. Also, the increased prevalence of sexually transmitted diseases among the teenage population is anticipated to favor market growth in the region. Favorable government policies including ‘Hum Do Humare Do’ by the Indian government are also projected to generate noteworthy revenue.

Research Nester
Get more information on this report: Request Free Sample PDF

Companies Dominating the Contraceptives Landscape

    • Novartis Pharmaceutical Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Agile Therapeutics, Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson Services, Inc.
    • Piramal Group
    • Viatris Inc.
    • Pfizer Inc.
    • Bayer AG
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc.

In the News

  • Perrigo Company plc declared that HRA Pharma submitted its application to U.S. FDA for ‘Opill’, a progestin-only daily birth control pill that would be the first OTC birth control pill in the United States.

  • United States Food and Drug Administration (U.S FDA) approved permission for ‘Natural Cycles’, the first mobile application for contraception to prevent unwanted pregnancy. The app predicts the woman’s fertile days and menstrual cycles based on body temperature.

Author Credits:  Radhika Pawar

  • Report ID: 4635
  • Published Date: Feb 22, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing disposable income and rising world population along with elevating risks of abortion are the major factors driving the growth of the contraceptives market.

The market is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2033.

Lack of social acceptance and side effects occurrence such as nausea, headache along with lack of social acceptance are estimated to be the growth-hindering factors for the market expansion.

The market in the North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Novartis Pharmaceutical Corporation, Agile Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Piramal Group, Viatris Inc., Pfizer Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, age, gender, end-user, and by region.

The pharmacies segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Contraceptives Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying